Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John A Lust, MD, PhD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Unversity of Cape Town - Groote Schuur Hospital
Cape Town, South Africa
- Pretoria East Hospital
Pretoria, South Africa
- the University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Fred Hutchinson Cancer Research Center/university of Washington Medical Center
Seattle, Washington, United States
- West Virginia University Mary Babb Randolf Cancer Center
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2011
- Primary completion
- 31 Oct 2014
- Completion
- 31 Dec 2014
- Last update posted
- 11 Sept 2014
- Registered enrollment
- 15
- Registry id
- NCT01435720
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.